Dr. Pettaway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-3250Fax+1 713-794-4824
Education & Training
- University of Texas Health Science Center at HoustonResidency, Urology, 1991 - 1993
- University of Texas Southwestern Medical CenterResidency, Urology, 1987 - 1991
- University of Texas Southwestern Medical CenterResidency, Surgery, 1986 - 1987
- University of Texas Southwestern Medical Center/Parkland Memorial HospitalInternship, Transitional Year, 1983 - 1984
- Lewis Katz School of Medicine at Temple UniversityClass of 1983
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2024 - 2026
- GA State Medical License 2024 - 2026
- TN State Medical License 2024 - 2026
- TX State Medical License 1984 - 2026
- LA State Medical License 2024 - 2025
- MS State Medical License 2024 - 2025
- American Board of Urology Urology
- Join now to see all
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence Start of enrollment: 1999 Jun 14
- Effects of Pomegranate Juice or Extract on Rising PSA Levels in Men Following Primary Therapy for Prostate Cancer Start of enrollment: 2006 Dec 01
- Quality of Life in Men With High Risk Localized Prostate Cancer Start of enrollment: 2006 May 01
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsAtlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulationAlexander Gusev, Huwenbo Shi, Gleb Kichaev, Mark Pomerantz, Fugen Li
Nature Communications. 2016-04-07 - 29 citationsImmune-based therapies in penile cancer.Vidhu B Joshi, Philippe E Spiess, Andrea Necchi, Curtis A Pettaway, Jad Chahoud
Nature Reviews. Urology. 2022-08-01 - 15 citationsSafety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.Talal El Zarif, Amin H Nassar, Gregory R Pond, Tony Zibo Zhuang, Viraj Master
Journal of the National Cancer Institute. 2023-12-06
Other
- Carcinoma of the penis: Clinical presentation and diagnosisPettaway CA
http://www.uptodate.com/contents/carcinoma-of-the-penis-clinical-presentation-and-diagnosis
UpToDate, Wolters Kluwer Health - 2012-08-21 - Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosisPettaway CA
http://www.uptodate.com/contents/carcinoma-of-the-penis-epidemiology-risk-factors-staging-and-progno
UpToDate, Wolters Kluwer Health - 2013-01-30
Press Mentions
- 7 Things to Know About Penile CancerJuly 20th, 2020
- MDACC 2018: Debate: Organ Preservation in Penile CancerNovember 10th, 2018
- Synthetic Lethality Between Androgen Receptor Signalling and the PARP Pathway in Prostate CancerAugust 29th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: